SB202190 hydrochloride CAS: 350228-36-3
MF: C20H14FN3O•HCl
MW: 367.80
An inhibitor of the isoforms p38α and p38&beta.

SB202190 hydrochloride (CAS 350228-36-3)

SB202190 hydrochloride | CAS 350228-36-3 is rated 5.0 out of 5 by 1.
  • y_2020, m_2, d_18, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_222294, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 142ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Synonym: 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol Monohydrochloride
Application: An inhibitor of the isoforms p38α and p38&beta
CAS Number: 350228-36-3
Purity: ≥96%
Molecular Weight: 367.80
Molecular Formula: C20H14FN3O•HCl
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

SB202190 hydrochloride is a water soluble form of the potent p38 (SAPK2a) inhibitor SB202190 (sc-202334).

Physical State :
Solid
Storage :
Store at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
6419751
SMILES :
C1=CC(=O)C=CC1=C2NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F.Cl

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

SB202190 hydrochloride  Product Citations

See how others have used SB202190 hydrochloride. Click on the entry to view the PubMed entry .

Citations 1 to 9 of 9 total

PMID: # 28396222  Zhang, L.|Xu, P.|Wang, X.|Zhang, M.|Yan, Y.|Chen, Y.|Zhang, L.|Zhang, L.| et al. 2017. Int. J. Biochem. Cell Biol. 87: 69-76.

PMID: # 28747804  van der Linden, M. et al. 2017. Sci Rep. 7: 6529.

PMID: # 26699492  Olabisi, OA. et al. 2016. Proc. Natl. Acad. Sci. U.S.A. 113: 830-7.

PMID: # 25834401  Li, JP. et al. 2015. Drug Des Devel Ther. 9: 1627-52.

PMID: # 25638774  Abdalla, MY. et al. 2015. Redox Biol. 4: 328-39.

PMID: # 25197927  Zhang, M. et al. 2014. Cell Transplant. 23: 1061-73.

PMID: # 23457635  Fields, J. et al. 2013. PLoS ONE. 8: e56891.

PMID: # 23029125  Mamik, MK. et al. 2012. PLoS ONE. 7: e45596.

PMID: # 11295527  Anania, FA. et al. 2001. Free Radic. Biol. Med. 30: 846-57.

Citations 1 to 9 of 9 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 118ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Gardner Gardner, S. et al. (PubMed 26246429) used SB202190, a p38 inhibitor, to demonstrate that activity of p38 / is important not only for the early phases of myoblast differentiation, but also later stages of myocyte fusion and myofibrillogenesis. -SCBT Publication Review
Date published: 2015-04-15
  • y_2020, m_2, d_18, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_222294, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 9ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.